Leef Brands (LEEEF) Finished Goods (2024 - 2026)

Leef Brands (LEEEF) reported Finished Goods of $981292.0 for Q1 2026, down 27.12% sequentially from $1.3 million in Q4 2025.

Leef Brands (LEEEF) Finished Goods (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Finished Goods data on file, last reported at $981292.0 in Q1 2026.

  • For the quarter ending Q1 2026, Finished Goods changed N/A year-over-year to $981292.0; the trailing twelve-month figure through Mar 2026 stood at $981292.0 (changed N/A YoY), and the FY2025 full-year result was $1.3 million, down 17.37% from the prior year.
  • Finished Goods eased to $981292.0 in Q1 2026, from $1.3 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $1.6 million in Q4 2024 to a low of $981292.0 in Q1 2026.
  • A 3-year average of $1.3 million and a median of $1.3 million in 2025 frame the typical range for Finished Goods.
  • Peak annual rise in Finished Goods reached 17.37% in 2025, while the deepest fall reached 17.37% in 2025.
  • Tracing LEEEF's Finished Goods over 3 years: stood at $1.6 million in 2024, then retreated by 17.37% to $1.3 million in 2025, then slipped by 27.12% to $981292.0 in 2026.
  • Business Quant data shows LEEEF's Finished Goods at $981292.0 in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 981,292.00
Dec 31, 2025 1.35 Mn
Dec 31, 2024 1.63 Mn